| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |